Plus Therapeutics Inc (NASDAQ:PSTV) has a beta value of 0.71 and has seen 1.09 million shares traded in the recent trading session. The company, currently valued at $7.73M, closed the recent trade at $1.31 per share which meant it lost -$0.05 on the day or -3.68% during that session. The PSTV stock price is -112.21% off its 52-week high price of $2.78 and 12.98% above the 52-week low of $1.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 14680.0 shares traded. The 3-month trading volume is 54.26K shares.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Sporting -3.68% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PSTV stock price touched $1.31 or saw a rise of 9.66%. Year-to-date, Plus Therapeutics Inc shares have moved -25.15%, while the 5-day performance has seen it change -0.76%. Over the past 30 days, the shares of Plus Therapeutics Inc (NASDAQ:PSTV) have changed -2.96%. Short interest in the company has seen 53956.0 shares shorted with days to cover at 0.62.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Plus Therapeutics Inc (PSTV) estimates and forecasts
Figures show that Plus Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -42.29% over the past 6 months, with this year growth rate of 52.83%, compared to 18.80% for the industry. Revenue growth from the last financial year stood is estimated to be 8.90%.
3 analysts offering their estimates for the company have set an average revenue estimate of 1.52M for the current quarter. 3 have an estimated revenue figure of 1.65M for the next ending quarter. Year-ago sales stood 1.24M and 1.31M respectively for this quarter and the next, and analysts expect sales will grow by 22.60% for the current quarter and 8.90% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 68.20% over the past 5 years.
PSTV Dividends
Plus Therapeutics Inc is expected to release its next earnings report on 2024-Nov-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
Insiders own 2.34% of the company shares, while shares held by institutions stand at 11.77% with a share float percentage of 12.05%. Investors are also buoyed by the number of investors in a company, with Plus Therapeutics Inc having a total of 13.0 institutions that hold shares in the company.
